Intravenous fluorescein overdose in a child undergoing fluorescein angiography

Rhea W Teng1, Michael T B Nguyen1, David G Hunter1

  • 1Department of Ophthalmology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.

Insights

A pediatric patient received a high dose of fluorescein dye during angiography. The child experienced temporary yellowing of skin and bodily fluids but had no lasting adverse effects.

Area of Science:

  • Ophthalmology
  • Toxicology
  • Pediatrics

Background:

  • Fluorescein angiography is a key imaging technique for pediatric retinal vascular conditions.
  • Fluorescein dye has a generally safe profile at recommended intravenous doses.
  • Limited data exists on intravenous supratherapeutic fluorescein exposure effects.

Observation:

  • A 10-month-old infant with incontinentia pigmenti received over four times the standard fluorescein dose.
  • The child exhibited significant yellow discoloration of skin, sclera, stool, and urine post-procedure.

Findings:

  • The supratherapeutic fluorescein dose led to transient, visible external and internal yellowing.
  • Toxicology assessment and 8-hour monitoring revealed no adverse sequelae.
  • The patient experienced no long-term complications following the overdose.

Implications:

  • This case provides novel insight into the effects of intravenous fluorescein overdose in a pediatric patient.
  • It supports the generally reassuring safety profile of fluorescein dye even at supratherapeutic levels.
  • Highlights the importance of vigilant monitoring after potential medication errors in pediatric procedures.